(Q38765934)

6 September 2017

Lipotoxicity as a trigger factor of renal disease (English)

1 reference

6 September 2017

Adriana Izquierdo-Lahuerta

series ordinal

1

1 reference

6 September 2017

Cristina Martínez-García

series ordinal

2

1 reference

6 September 2017

Gema Medina-Gómez

series ordinal

3

1 reference

6 September 2017

8 March 2016

1 reference

6 September 2017

8

1 reference

inferred from page(s)

published in

Journal of Nephrology

1 reference

6 September 2017

29

1 reference

6 September 2017

5

1 reference

6 September 2017

603-610

1 reference

https://scigraph.springernature.com/pub.10.1007/s40620-016-0278-5

6 September 2017

0 references

cites work

Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

New insights into human minimal change disease: lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Overview: obesity: what does it have to do with kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

FFAs: do they play a role in vascular disease in the insulin resistance syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Renal lipid metabolism and lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Albuminuria and renal injury--beware of proteins bearing gifts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

It's not how fat you are, it's what you do with it that counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

APOL1 risk variants, race, and progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Lipid biology of the podocyte--new perspectives offer new opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

The role of reactive oxygen species in insulin signaling in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Lipid-protein interactions along the slit diaphragm of podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Renal Lipotoxicity-Associated Inflammation and Insulin Resistance Affects Actin Cytoskeleton Organization in Podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Insulin signaling to the glomerular podocyte is critical for normal kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Lipotoxicity in renal proximal tubular cells: relationship between endoplasmic reticulum stress and oxidative stress pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Lipid phosphatase SHIP2 downregulates insulin signalling in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Prolonged treatment of primary hepatocytes with oleate induces insulin resistance through p38 mitogen-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

The role of nuclear receptors in the kidney in obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

PPARalpha agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

The complex role of PPARgamma in renal dysfunction in obesity: managing a Janus-faced receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Statins in chronic kidney disease and kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Immunoliposome targeting to mesangial cells: a promising strategy for specific drug delivery to the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Anti-alpha8 integrin immunoliposomes in glomeruli of lupus-susceptible mice: a novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Targeted transfection increases siRNA uptake and gene silencing of primary endothelial cells in vitro--a quantitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Targeting podocyte-associated diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Signal transduction in podocytes--spotlight on receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Identification of novel long noncoding RNAs associated with TGF-β/Smad3-mediated renal inflammation and fibrosis by RNA sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

MicroRNAs in kidney physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Lipid mediators in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Genome regulation by long noncoding RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Regulation of the apolipoprotein gene cluster by a long noncoding RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-016-0278-5

Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats

21 January 2018

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma agonists in kidney disease--future promise, present fears

1 reference

12 December 2020

Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines.

1 reference

12 December 2020

Deterioration in renal function associated with fibrate therapy.

1 reference

12 December 2020

Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet

1 reference

12 December 2020

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.

1 reference

12 December 2020

PPAR-gamma agonist protects podocytes from injury

1 reference

12 December 2020

The role of statins in chronic kidney disease

1 reference

12 December 2020

Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy

1 reference

12 December 2020

Fatty acids exacerbate tubulointerstitial injury in protein-overload proteinuria

1 reference

12 December 2020

Telmisartan counteracts TGF-β1 induced epithelial-to-mesenchymal transition via PPAR-γ in human proximal tubule epithelial cells

1 reference

12 December 2020

Adiponectin regulates albuminuria and podocyte function in mice

1 reference

12 December 2020

Dietary fish oil reduces progression of established renal disease in (NZB x NZW)F1 mice and delays renal disease in BXSB and MRL/1 strains

1 reference

12 December 2020

10.1007/S40620-016-0278-5

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

0 references

1 reference